Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

STEMLINE THERAPEUTICS INC (STML)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -76.8-85.0-67.8-38.3-37.2-28.8-24.2-6.3
Depreciation and amortization   [+]0.10.10.00.10.20.20.1 
Stock-based compensation  26.213.98.67.45.24.44.80.6
Change in working capital   [+]-16.8-1.210.31.26.0-1.72.71.5
Other operating activities  -0.40.0-0.7-0.50.30.20.50.0
Cash from operations  -67.7-72.2-49.6-30.1-25.6-25.7-16.1-4.1
   
Capital expenditures  0.00.00.00.00.00.00.00.0
Purchases of short-term investments, net     26.7-50.96.4-40.2 
Other cash from investing  -99.210.8-4.40.00.0 -0.5 
Cash from investing  -99.210.8-4.426.7-50.96.4-40.70.0
   
Issuance of common stock, net  168.463.948.2 64.1 97.7 
Option exercises  2.11.60.10.30.70.11.3 
Other cash from financing  4.73.70.40.61.50.32.60.3
Cash from financing  171.066.048.50.464.90.199.00.3
   
Free cash flow  -67.7-72.2-49.6-30.1-25.6-25.7-16.1-4.1
        Per share (diluted)  ($1.61)($2.54)($2.15)($1.69)($1.48)($1.99)($1.56)($1.20)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy